James Loerop
Chief Business Officer · Aclaris Therapeutics, Inc.
Individual
- 2026
- Feb 6, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James Loerop files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Braden Michael Leonard - $1.36M in ACRS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James Loerop?
James Loerop is a corporate insider, tracked as Chief Business Officer of Aclaris Therapeutics, Inc. (ACRS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did James Loerop last file a Form 4?
The most recent primary Form 4 on record is dated 6 February 2026, one of 3 filings going back to 2026.
